Phase 3CompletedAge-related condition
Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido
A Randomized, Double-Blind, Placebo-controlled, Parallel-group, 52-week Study to Evaluate the Efficacy/Safety of Transdermal Patches Delivering Testosterone in Menopausal Women With Low Libido Not Receiving Estrogen Therapy
- Sponsor
- Warner Chilcott (Industry)
- Enrollment
- 814 enrolled
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Testosterone (transdermal patches); Placebo patch
- Ages
- adults, older adults
- Registry
- NCT00131495
Full record on ClinicalTrials.gov
From the registry
This study is designed to evaluate the efficacy and safety of 2 doses of the transdermal testosterone patch in naturally or surgically menopausal women with low libido who are not receiving systemic estrogen or estrogen progestin therapy.
Primary outcomes
- Total satisfying sexual activity over 24 weeks
History
Last registry update
Study completion
Primary completion
Registered
Started